UBS Group’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-351
| Closed | -$4K | – | 10370 |
|
2022
Q2 | $4K | Sell |
351
-546
| -61% | -$6.22K | ﹤0.01% | 8209 |
|
2022
Q1 | $13K | Sell |
897
-60
| -6% | -$870 | ﹤0.01% | 7077 |
|
2021
Q4 | $21K | Buy |
957
+813
| +565% | +$17.8K | ﹤0.01% | 6705 |
|
2021
Q3 | $4K | Buy |
144
+114
| +380% | +$3.17K | ﹤0.01% | 7609 |
|
2021
Q2 | $1K | Sell |
30
-1,173
| -98% | -$39.1K | ﹤0.01% | 8177 |
|
2021
Q1 | $38K | Buy |
1,203
+1,173
| +3,910% | +$37.1K | ﹤0.01% | 5804 |
|
2020
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 7265 |
|
2020
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 6998 |
|
2020
Q2 | $1K | Sell |
30
-1,123
| -97% | -$37.4K | ﹤0.01% | 6987 |
|
2020
Q1 | $40K | Buy |
+1,153
| New | +$40K | ﹤0.01% | 5118 |
|
2019
Q4 | – | Sell |
-756
| Closed | -$19K | – | 7295 |
|
2019
Q3 | $19K | Buy |
756
+111
| +17% | +$2.79K | ﹤0.01% | 5817 |
|
2019
Q2 | $14K | Sell |
645
-1,762
| -73% | -$38.2K | ﹤0.01% | 5992 |
|
2019
Q1 | $41K | Sell |
2,407
-87
| -3% | -$1.48K | ﹤0.01% | 4892 |
|
2018
Q4 | $29K | Buy |
2,494
+1,211
| +94% | +$14.1K | ﹤0.01% | 5604 |
|
2018
Q3 | $21K | Sell |
1,283
-327
| -20% | -$5.35K | ﹤0.01% | 5861 |
|
2018
Q2 | $20K | Buy |
+1,610
| New | +$20K | ﹤0.01% | 5785 |
|
2017
Q4 | – | Sell |
-277
| Closed | -$5K | – | 7056 |
|
2017
Q3 | $5K | Buy |
+277
| New | +$5K | ﹤0.01% | 6330 |
|